HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
27277studies shown
Showing 6,481-6,492 of 27,277
Drug study icon
CompletedEUCTR 2006-004783-31

A Double-Blind, Randomised, Parallel-Group, Placebo-Controlled, MultiCentre, Phase IIa Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Multiple Oral Dos...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Hungary
SchizophreniaHistorical research record
Countries
Hungary, Latvia
Sponsor
AstraZeneca AB
Biological study icon
CompletedEUCTR 2013-000212-22

A double-blind, randomised, placebo-controlled, parallel group study of GWP42003 as adjunctive therapy in the first line treatment of schizophrenia or related psychotic disorder

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Poland
SchizophreniaHistorical research record
Countries
United Kingdom, Poland, Romania
Sponsor
GW Research Ltd
Drug study icon
CompletedEUCTR 2016-003990-17

A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Sympto...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria
DepressionHistorical research record
Countries
Bulgaria, Germany, Hungary, + 2 others
Sponsor
Janssen-Cilag International NV
Drug study icon
CompletedACTRN12622000713796

Safety study of Single, Ascending, Subcutaneous Doses of FT-104 HCl in Depression

Official study title

A Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Single, Ascending, Subcutaneous Doses of FT-104 HCl In Healthy Volunteers Safety, Tolerability, and Pharmacokinetics of Subcutaneous FT-104 HCl (SAIL-101)

This study has finished and is no longer accepting participants.

In Adelaide
DepressionInterventional studyAges 18–65
Countries
Australia
Sponsor
Field Trip Psychedelics Inc
Drug study icon
CompletedACTRN12606000272594

A double-blinded, study of modafinil for amphetamine withdrawal

Official study title

A double-blinded, placebo-controlled trial of modafinil for amphetamine withdrawal in adults who are currently dependent on amphetamines

This study has finished and is no longer accepting participants.

Location not clearly listed
Mental healthInterventional studyAges 18+
Countries
Sponsor
Government Department of Health and Aging.
Drug study icon
CompletedNCT01094249

Valproic Acid and Paliperidone Extended-Release (ER) for schizophrenia

Official study title

An Open-Label, Drug-Drug Interaction Study to Evaluate the Effect of Paliperidone Extended-Release on the Steady-State Pharmacokinetics of Valproic Acid in Clinically Stable Subjects With Schizophrenia, Bipolar I Disorder or Schizoaffective Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Kissimmee
Bipolarity, SchizophreniaMedication studyAges 18–65
Countries
United States
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Drug study icon
CompletedNCT01060228

A Drug Interaction Study of Valproic Acid and Single-dose Paliperidone Extended-Release (ER) in Healthy Men

Official study title

An Open-Label, Drug-Drug Interaction Study Between Steady-State Valproic Acid and Single-Dose Paliperidone Extended-Release in Healthy Men

This study has finished and is no longer accepting participants.

Location not clearly listed
SchizophreniaMedication studyAges 18–55
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Drug study icon
CompletedNCT03451344

A Electronic System to Improve Recovery Outcomes in people with Drug Use Disorder

Official study title

A Community-based Addiction Rehabilitation Electronic System to Improve Recovery Outcomes in Patients With Drug Use Disorder: Protocol for a Randomized Controlled Trial

This study has finished and is no longer accepting participants.

In Shanghai
AddictionInterventional studyAges 20–50
Countries
China
Sponsor
Shanghai Mental Health Center

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.